arrow
R

Rachael Natrajan

The Institute of Cancer Research
H指数:66
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The anion channel GPR89 is a tumor-specific dependency in breast cancer

GPR89阴离子通道是乳腺癌的肿瘤特异性依赖

2026-08-240
OA
Co-occurrence of transcriptionally distinct persister cell states underpins neoadjuvant therapy resistance in triple‑negative breast cancer

转录异质性持久细胞状态的共发生是三阴性乳腺癌新辅助治疗耐药的基础

2026-04-090
OA
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer

浸润性小叶乳腺癌患者的临床挑战和建议的解决方案

2025-07-210
OAAI
SF3B1 hotspot mutations confer sensitivity to PARP inhibition through a defective replication stress response
2023-12-010
PRE
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
2023-07-3118
OAAI
Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition
2023-03-010
PRE
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2021-02-1510
OA